SARS-CoV-2: clinical or host-associated
BioSampleModel
2023-06-23T02:11:49Z
ENA-FIRST-PUBLIC
2023-06-23T02:11:49Z
ENA-LAST-UPDATE
SAMN35841519
External Id
NYGC
INSDC center name
2023-06-23T02:11:49Z
INSDC first public
2023-06-23T02:11:49Z
INSDC last update
public
INSDC status
SRS18040180
SRA accession
36484-21-2-9573206
Submitter Id
PRJNA766678
bioproject_accession
NCBI
broker name
Universidad Autonoma de Yucatan
collected_by
2021-09-06
collection_date
Mexico: Yucatan, Kanasin, Los Encinos
geo_loc_name
EPI_ISL_13136607
gisaid_accession
hCoV-19/Mexico/YUC-NYGC-36484-21/2021
gisaid_virus_name
Homo sapiens
host
36
host_age
COVID-19
host_disease
female
host_sex
NP
host_subject_id
SARS-CoV-2/Human/Mexico/YUC-NYGC-36484-21/2021
isolate
clinical
isolation_source
Severe acute respiratory syndrome coronavirus 2
organism
Severe acute respiratory syndrome coronavirus 2
organism
36484-21
sample_name
20
sars_cov_2_diag_pcr_ct_value_1
Severe acute respiratory syndrome coronavirus 2
scientific_name
New York Genome Center
sequenced_by
SARS-CoV-2: Clinical Severe acute respiratory syndrome coronavirus 2 sample collected from NYC metropolitan area
title
ASTRAZENECA
vaccine_received